| 000 | 01752 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515225041.0 | ||
| 264 | 0 | _c20101208 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1421-9824 | ||
| 024 | 7 |
_a10.1159/000313534 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKester, Maartje I | |
| 245 | 0 | 0 |
_aDiagnostic impact of CSF biomarkers in a local hospital memory clinic. _h[electronic resource] |
| 260 |
_bDementia and geriatric cognitive disorders _c2010 |
||
| 300 |
_a491-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xcerebrospinal fluid |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBiomarkers _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aCognition Disorders _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aDementia _xcerebrospinal fluid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptide Fragments _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aPhosphoproteins _xcerebrospinal fluid |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_atau Proteins _xcerebrospinal fluid |
| 700 | 1 | _aBoelaarts, Leo | |
| 700 | 1 | _aBouwman, Femke H | |
| 700 | 1 | _aVogels, Raymond L | |
| 700 | 1 | _aGroot, Erwin R | |
| 700 | 1 | _avan Elk, Evert J | |
| 700 | 1 | _aBlankenstein, Marinus A | |
| 700 | 1 | _avan der Flier, Wiesje M | |
| 700 | 1 | _aScheltens, Philip | |
| 773 | 0 |
_tDementia and geriatric cognitive disorders _gvol. 29 _gno. 6 _gp. 491-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000313534 _zAvailable from publisher's website |
| 999 |
_c19873693 _d19873693 |
||